Stay updated on PSMA [Lu-177]-PNT2002 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the PSMA [Lu-177]-PNT2002 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PSMA [Lu-177]-PNT2002 in mCRPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T07:10:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:16:25.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:20:57.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    No new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.
    Difference
    13%
    Check dated 2024-11-23T04:03:20.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The website has updated to include new information about POINT Biopharma, a subsidiary of Eli Lilly and Company, and has released a new version (v2.12.2) while removing the previous version (v2.12.1) and some dated entries.
    Difference
    20%
    Check dated 2024-11-08T17:59:46.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    Eli Lilly and Company has been added in version v2.12.1, while the previous version v2.12.0 has removed the mention of POINT Biopharma, a subsidiary of Eli Lilly.
    Difference
    3%
    Check dated 2024-11-01T10:24:10.000Z thumbnail image

Stay in the know with updates to PSMA [Lu-177]-PNT2002 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PSMA [Lu-177]-PNT2002 in mCRPC Clinical Trial page.